|
DNAJC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61973999999176E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.70509999999746E-05 |
| Normal-vs-Stage2 |
2.443100E-04 |
| Normal-vs-Stage3 |
1.82708999999504E-05 |
| Normal-vs-Stage4 |
4.811100E-04 |
| Stage1-vs-Stage2 |
2.882800E-01 |
| Stage1-vs-Stage3 |
3.090600E-01 |
| Stage1-vs-Stage4 |
6.197400E-01 |
| Stage2-vs-Stage3 |
7.770200E-01 |
| Stage2-vs-Stage4 |
6.715600E-01 |
| Stage3-vs-Stage4 |
8.123200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.96289999996069E-06 |
| Normal-vs-AfricanAmerican |
6.041100E-03 |
| Normal-vs-Asian |
1.882430E-03 |
| Caucasian-vs-AfricanAmerican |
9.923600E-01 |
| Caucasian-vs-Asian |
7.004000E-01 |
| AfricanAmerican-vs-Asian |
7.911600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.555100E-04 |
| Normal-vs-Female |
1.5132799999984E-05 |
| Male-vs-Female |
5.856400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.73739999999834E-05 |
| Normal-vs-Age(41-60Yrs) |
2.48219999999799E-05 |
| Normal-vs-Age(61-80Yrs) |
1.24000000001345E-06 |
| Normal-vs-Age(81-100Yrs) |
2.050400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.537400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.397800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.268200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.588600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.608000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.329200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.728000E-02 |
| Classical-VS-Follicular |
8.221700E-04 |
| Classical-VS-Other |
9.132600E-01 |
| Classical-VS-Normal |
1.057170E-03 |
| Tall-VS-Follicular |
7.752000E-01 |
| Tall-VS-Other |
2.942400E-01 |
| Tall-VS-Normal |
8.43380000000726E-05 |
| Follicular-VS-Other |
2.749600E-01 |
| Follicular-VS-Normal |
9.75279999981815E-07 |
| Other-VS-Normal |
2.372000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93850000052009E-07 |
| Normal-vs-N1 |
1.619740E-02 |
| N0-vs-N1 |
5.783600E-02 |
|
|
